Results 201 to 210 of about 171,882 (296)

Accelerated Biological Aging, Genetic Predisposition, and Incident Valvular Heart Disease. [PDF]

JACC Asia
Zhu YJ, Suo XY, Guo J, Lu S, Zhang JX, Bo YC, Han ZY, Qiu CG.   +7 more
europepmc   +1 more source

Role of SoxE transcription factors in development and disease

Developmental Dynamics, EarlyView.
Abstract Sox8, Sox9, and Sox10 arose by multiple rounds of genome duplications from a single SoxE gene in ancestral vertebrates. In this review, we will briefly discuss the molecular structure and function of SoxE transcription factors and their evolutionary origin. We will then discuss their expression, function, and developmental disorders.
Merin Lawrence, Gerhard Schlosser
wiley   +1 more source

Valvular Heart Disease in Non-Valvular Heart Failure Continuum: The Role of Cardiopulmonary Exercise Testing. [PDF]

Biomedicines
Mavromoustakou K, Botis M, Iliakis P, Leontsinis I, Xydis P, Dimitriadis K, Chrysohoou C, Tsioufis K.   +7 more
europepmc   +1 more source

Association of COPD with adverse outcomes in heart failure patients with preserved ejection fraction

ESC Heart Failure, Volume 12, Issue 2, Page 799-808, April 2025.
Abstract We performed a systematic review and meta‐analysis to detect the impact of chronic obstructive pulmonary disease (COPD) on the prognosis of heart failure patients with preserved ejection fraction (HFpEF). We systematically screened eligible literature from three electronic databases, PubMed, EMBASE and Cochrane Library, up to April 2023.
Shuo Xu, Zhenbang Gu, Wengen Zhu, Shenghui Feng   +3 more
wiley   +1 more source

Automatic Diagnosis of Left Valvular Heart Disease Based on Artificial Intelligence Stethoscope. [PDF]

JACC Adv
Zhou Z, Xie K, Huang Y, Zhang W, Li B, Zhong J, Liao X, Wang C, Zhuang X.   +8 more
europepmc   +1 more source

Gut microbiota‐related modulation of immune mechanisms in post‐infarction remodelling and heart failure

ESC Heart Failure, Volume 12, Issue 2, Page 942-954, April 2025.
Abstract The immune system has long been recognized as a key driver in the progression of heart failure (HF). However, clinical trials targeting immune effectors have consistently failed to improve patient outcome across different HF aetiologies. The activation of the immune system in HF is complex, involving a broad network of pro‐inflammatory and ...
Johann Roessler, Friederike Zimmermann, Bettina Heidecker, Ulf Landmesser, Arash Haghikia   +4 more
wiley   +1 more source

Instruments Used to Assess Health-Related Quality of Life in Valvular Heart Disease: A Narrative Review. [PDF]

Cureus
Marinescu AD, Costache VS.
europepmc   +1 more source

Incident heart failure: comparing management and outcome in primary and hospital settings in Western Sweden 2008–2017

ESC Heart Failure, Volume 12, Issue 2, Page 832-838, April 2025.
Abstract Aim Heart failure (HF) is a highly prevalent condition managed in both primary care (PC) and hospital care (HC)‐based settings. HF patients managed in these two settings may differ in their demography, comorbidities and outcomes, so we aimed to compare the patient management in PC and HC in the Västra Götaland Region (VGR) in Sweden.
Xiaojing Chen, Aldina Pivodic, Maria Schaufelberger, Annika Rosengren, Michael Fu   +4 more
wiley   +1 more source

4D Flow MRI Velocity and Turbulence Mapping in Mild Valvular Heart Disease. [PDF]

J Magn Reson Imaging
Bianchessi T, Trenti C, Carlhäll CJ, Ebbers T, Engvall J, Vanky F, Viola F, Dyverfeldt P.   +7 more
europepmc   +1 more source

Electrocardiography: Atrial Fibrillation [PDF]

, 2011
Ginter, James F., Loftis, Patrick
core   +1 more source